- Home
- CEE vs ZTEK Comparison
CEE vs ZTEK Comparison
Compare CEE & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CEE
- ZTEK
- Stock Information
- Founded
- CEE 1990
- ZTEK 2008
- Country
- CEE Germany
- ZTEK Canada
- Employees
- CEE N/A
- ZTEK N/A
- Industry
- CEE Finance Companies
- ZTEK Major Chemicals
- Sector
- CEE Finance
- ZTEK Industrials
- Exchange
- CEE Nasdaq
- ZTEK Nasdaq
- Market Cap
- CEE 105.5M
- ZTEK 91.6M
- IPO Year
- CEE N/A
- ZTEK N/A
- Fundamental
- Price
- CEE $16.19
- ZTEK $1.01
- Analyst Decision
- CEE
- ZTEK
- Analyst Count
- CEE 0
- ZTEK 0
- Target Price
- CEE N/A
- ZTEK N/A
- AVG Volume (30 Days)
- CEE 22.0K
- ZTEK 837.3K
- Earning Date
- CEE 01-01-0001
- ZTEK 11-13-2025
- Dividend Yield
- CEE 3.86%
- ZTEK N/A
- EPS Growth
- CEE N/A
- ZTEK N/A
- EPS
- CEE N/A
- ZTEK N/A
- Revenue
- CEE N/A
- ZTEK $678,078.00
- Revenue This Year
- CEE N/A
- ZTEK N/A
- Revenue Next Year
- CEE N/A
- ZTEK N/A
- P/E Ratio
- CEE N/A
- ZTEK N/A
- Revenue Growth
- CEE N/A
- ZTEK 2519.47
- 52 Week Low
- CEE $7.80
- ZTEK $0.50
- 52 Week High
- CEE $10.32
- ZTEK $1.84
- Technical
- Relative Strength Index (RSI)
- CEE 47.59
- ZTEK 63.78
- Support Level
- CEE $15.87
- ZTEK $0.65
- Resistance Level
- CEE $16.45
- ZTEK $1.07
- Average True Range (ATR)
- CEE 0.56
- ZTEK 0.12
- MACD
- CEE -0.08
- ZTEK 0.04
- Stochastic Oscillator
- CEE 41.32
- ZTEK 62.90
About CEE The Central and Eastern Europe Fund Inc. (The)
CENTRAL & EASTERN EUROPE FUND, INC. is a closed-end management investment company. The Fund's objective is to seek long-term capital appreciation. It invests in the equity or equity-linked securities of issuers domiciled in Central and Eastern Europe.
About ZTEK Zentek Ltd.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.